These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9225804)

  • 1. Technetium-99m-meso-HMPAO as a potential agent to image cerebral glutathione content.
    Sasaki T; Senda M
    J Nucl Med; 1997 Jul; 38(7):1125-9. PubMed ID: 9225804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of antioxidative ability in brain: technetium-99m-meso-HMPAO as an imaging agent for glutathione localization.
    Sasaki T; Toyama H; Oda K; Ogihara-Umeda I; Nishigori H; Senda M
    J Nucl Med; 1996 Oct; 37(10):1698-701. PubMed ID: 8862315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of glutathione localization in brain using 99mTc meso-HMPAO.
    Sasaki T; Senda M
    J Nucl Med; 1999 Jun; 40(6):1056-60. PubMed ID: 10452324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of glutathione and technetium-99m-meso-HMPAO in normal and diethyl maleate-treated mouse brain mitochondria.
    Sasaki T; Fujibayashi Y; Senda M
    J Nucl Med; 1998 Dec; 39(12):2178-83. PubMed ID: 9867165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of (99m)Tc-d,l-HMPAO for estimation of GSH content in tumor tissues.
    Shimura N; Musya A; Hashimoto T; Kojima S; Kubodera A; Sasaki T
    Nucl Med Biol; 2000 Aug; 27(6):577-80. PubMed ID: 11056372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytes as a predominant cellular site of (99m)Tc-HMPAO retention.
    Zerarka S; Pellerin L; Slosman D; Magistretti PJ
    J Cereb Blood Flow Metab; 2001 Apr; 21(4):456-68. PubMed ID: 11323531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ligand structure on glutathione-mediated decomposition of propylene amine oxime derivatives.
    Roth CA; Hoffman TJ; Corlija M; Volkert WA; Holmes RA
    Int J Rad Appl Instrum B; 1992 Oct; 19(7):783-90. PubMed ID: 1399700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of glutathione in lung retention of 99mTc-hexamethylpropyleneamine oxime in two unique rat models of hyperoxic lung injury.
    Audi SH; Roerig DL; Haworth ST; Clough AV
    J Appl Physiol (1985); 2012 Aug; 113(4):658-65. PubMed ID: 22628374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxido-reductive state: the major determinant for cellular retention of technetium-99m-HMPAO.
    Jacquier-Sarlin MR; Polla BS; Slosman DO
    J Nucl Med; 1996 Aug; 37(8):1413-6. PubMed ID: 8708786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is 99Tcm hexamethyl-propyleneamine oxime uptake in the tissues related to glutathione cellular content?
    el-Shirbiny AM; Sadek S; Owunwanne A; Yacoub T; Suresh L; Abdel-Dayem HM
    Nucl Med Commun; 1989 Dec; 10(12):905-11. PubMed ID: 2622593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake mechanism of technetium-99m-d, 1-HMPAO in cell cultures of the dissociated postnatal rat cerebellum.
    Suess E; Huck S; Reither H; Hörtnagl H; Angelberger P
    J Nucl Med; 1992 Jan; 33(1):108-14. PubMed ID: 1730973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
    Pijarowska-Kruszyna J; Karczmarczyk U; Jaroń AW; Laszuk E; Radzik M; Garnuszek P; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2017; 20(2):88-94. PubMed ID: 28555448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99Tcm-labelled meso-HMPAO and glutathione content of human lung tumours.
    Rowell NP; McCready VR; Cronin B; Pepper J; Higley B; Burke JF; Tyrrell DA
    Nucl Med Commun; 1989 Jul; 10(7):503-8. PubMed ID: 2552364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The retention mechanism of technetium-99m-HM-PAO: intracellular reaction with glutathione.
    Neirinckx RD; Burke JF; Harrison RC; Forster AM; Andersen AR; Lassen NA
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S4-12. PubMed ID: 3192641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
    van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB
    J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m HM-PAO stereoisomers: differences in interaction with glutathione.
    Ballinger JR; Reid RH; Gulenchyn KY
    J Nucl Med; 1988 Dec; 29(12):1998-2000. PubMed ID: 3193211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights on flow-independent mechanisms of 99mTc-HMPAO retention in nervous tissue: in vitro study.
    Colamussi P; Calò G; Sbrenna S; Uccelli L; Bianchi C; Cittanti C; Siniscalchi A; Giganti M; Roveri R; Piffanelli A
    J Nucl Med; 1999 Sep; 40(9):1556-62. PubMed ID: 10492379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of gamma-glutamylcysteine synthetase subunit gene expression in retinal Müller cells by oxidative stress.
    Lu SC; Bao Y; Huang ZZ; Sarthy VP; Kannan R
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1776-82. PubMed ID: 10393048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-individual differences between technetium-99m-HMPAO and technetium-99m-ECD in the normal medial temporal lobe.
    Oku N; Matsumoto M; Hashikawa K; Moriwaki H; Ishida M; Seike Y; Terakawa H; Watanabe Y; Uehara T; Nishimura T
    J Nucl Med; 1997 Jul; 38(7):1109-11. PubMed ID: 9225799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: a comparison.
    Asenbaum S; Brücke T; Pirker W; Pietrzyk U; Podreka I
    J Nucl Med; 1998 Apr; 39(4):613-8. PubMed ID: 9544665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.